Echocardiographic Characteristics of High Endurance Israeli Athletes

NCT ID: NCT00634335

Last Updated: 2008-12-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

81 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-03-31

Study Completion Date

2009-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to characterize the cardiac adaptive changes of professional Israeli bicyclists by using echocardiography.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Adaptive cardiac changes, such as enlargement of left ventricle mass and enlargement of left ventricular wall was observed in athletes. The physiological limit of remodeling changes in accordance to sex, type of activity, intensity of activity, genetics and race.

Although many studies were conducted on this subject, it is still impossible to predict if an athlete from a certain sport will develop cardiac changes and their what will those changes characteristics will be.

Sudden cardiac death is the leading cause of death among young athletes, this is because of high physical activity in the presence of a hidden heart disease, therefore there is much debate about the needed screening tests for athletes.

In Israel, there is only one study in this subject that showed no significant cardiac changes in Olympic athletes of various types of sports. the study didn't focused on high endurance sport athletes such as professional bicyclists although cardiac endurance is a main factor in cardiac changes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Athlete's Heart

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

sk

professional Israeli bicyclists

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Known athletes of the bicyclists organization of Israel or any other known organization for 2 year at least.
* Participated in at least one contest recognized by the bicyclists organization of Israel.
* Had been in training for the last 3 months at least, which included minimum of 8 hours a week in average

Exclusion Criteria

* Do not suffer any known cardiac disease
* Had declared that they are not using drugs which are forbidden by the Olympic committee
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Soroka University Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Soroka medical center

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sergio Kobal, MD

Role: PRINCIPAL_INVESTIGATOR

Soroka medical center, Israel

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Soroka University Medical Center

Beersheba, , Israel

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sergio Kobal, MD

Role: CONTACT

Phone: 972-8-6400133

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

KOBAL SERGIO, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

sor465808ctil

Identifier Type: -

Identifier Source: org_study_id